Home
Company
About us
Genito-urinary diseases
Governance
Board of Directors
Scientific Advisory Board
Management
R&D
Pipeline
Litoxetine (IXA-001)
IXA-002 & IXA-003
MAGenTA
Press
Contact
avril 10
, 2018
18 juin 2018
Press Release, Ixaltis-US Study starts, April 2018